Clinical and Translational Allergy

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
Bousquet J, Arnavielhe S, Bedbrook A, et al. Clinical and Translational Allergy 2018 8:45
Atopic dermatitis in cats and dogs: a difficult disease for animal and owners
Gedon NKY and Mueller RS. Clinical and Translational Allergy 2018 8:41
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
Zanichelli A, Magerl M, Longhurst HJ, Aberer W, et al. Clinical and Translational Allergy 2018 8:42

- OCTOBER 2018
Insulin allergy can be successfully managed by a systematic approach
Haastrup MB, Henriksen JE, Mortz CG and Bindslev-Jensen C. Clinical and Translational Allergy 2018 8:35.
Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab 
de Brito M, Huebner G, Murrel D, Bullpit P and Hartmann K. Clinical and Translational Allergy 2018 8:37.
POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project
Bousquet J, Anto JM, Annesi-Maesano I, Dedeu T, et al. Clinical and Translational Allergy 2018 8:36.

Assessing severity of anaphylaxis: a data-driven comparison of 23 instruments
Eller E, Muraro A, Dahl R, Gotthard Mortz C and Bindslev-Jensen C. Clinical and Translational Allergy 2018 8:29
Protease resistance of food proteins: a mixed picture for predicting allergenicity but a useful tool for assessing exposure
Akkerdaas J, Totis M, Barnett B, et al. Clinical and Translational Allergy 2018 8:30
Promoting and achieving excellence in the delivery of Integrated Allergy Care: the European Academy of Allergy & Clinical Immunology competencies for allied health professionals working in allergy
Skypala IJ, de Jong NW, Angier E, et al. Clinical and Translational Allergy 2018 8:31

- AUGUST 2018
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells
J. Hu, J. Chen, L. Ye, et. al. Clinical and Translational Allergy. 2018:8:27
DOI: 10.1186/s13601-018-0213-z
Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy
J. Köther, A. Mandl, S. Allekotte, et. al. Clinical and Translational Allergy. 2018:08:28
DOI: 10.1186/s13601-018-0214-y

- JULY 2018
Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort
R. Muñoz-Cano, P. Ribó, G. Araujo, et. al. Clinical and Translational Allergy. 2018;8:23
DOI: 10.1186/s13601-018-0212-0
Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy
J. Köther, A. Mandl, S. Allekotte, et. al. Clinical and Translational Allergy. 2018;8:28
DOI: 10.1186/s13601-018-0214-y
Sinus computed tomography predicts clinical response to corticosteroids in chronic rhinosinusitis with nasal polyps
H. Hong, D. Wang, K. Sen Tan, et. al. Clinical and Translational Allergy. 2018;8:24
DOI: 10.1186/s13601-018-0211-1

- JUNE 2018
The feasibility of an allergy management support system (AMSS) for IgE-mediated allergy in primary care
B. M.J. FLokstra-de Blok, M. Thecla, B. Marian Wubs, et. al. Clinical and Translational Allergy. 2018;8:18.
DOI: 10.1186/s13601-018-0206-y
The impact of cold on the respiratory tract and its consequences to respiratory health
M. D’Amato, A. Molino, G. Calabrese, et. al. Clinical and Translational Allergy. 2018;8:20.
DOI: 10.1186/s13601-018-0208-9

- MAY 2018
Pollen and spore monitoring in the world
J. T. M. Buters, C. Antunes, A. Galveias, et. al. Clinical and Translational Allergy. 2018;8:9
DOI: 10.1186/s13601-018-0197-8
Consideration of methods for identifying mite allergens
Y. Cui, Q. Wang, H. Jia, et. al. Clinical and Translational Allergy. 2018;8:14
DOI: 10.1186/s13601-018-0200-4

- MARCH 2018
Interleukin-25 and eosinophils progenitor cell mobilization in allergic asthma
W. Tang, S. G. Smith, W. Du, et. al. Clinical and Translational Allergy 2018;8:5
DOI: 10.1186/s13601-018-0190-2

Development and validation of a standardized double-blind, placebo-controlled food challenge matrix for raw hazelnuts
M. Vandekerckhove, B. V. Droogenbroeck, M. De Loose, et. al. Clinical and Translational Allergy. 2018;8:3
Stevens–Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database
B. Sousa-Pinto, L. Araújo, A. Freitas, et. al. Clinical and Translational Allergy. 2018;8:2
DOI: 10.1186/s13601-017-0188-1

- JANUARY 2018
Prediction and prevention of allergy and asthma in EAACI journals (2016)
J. Bousquet, C. Grattan, T. Bieber, P. Matricardi, H. Uwe Simon et. al. Clinical and Translational Allergy. 2017;7:46
DOI: 10.1186/s13601-017-0185-4
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
A. Bożekl, K. Kołodziejczyk, R. Kozłowska, G. W. Canonica et. al. Clinical and Translational Allergy. 2017;7:43
DOI: 10.1186/s13601-017-0180-9
How to manage anaphylaxis in primary care
A. Alvarez-Perea,  L. K. Tanno, M. L. Baeza et. al. Clinical and Translational Allergy. 2017;7:45 DOI: 10.1186/s13601-017-0182-7

Is there a sex-shift in prevalence of allergic rhinitis and comorbid asthma from childhood to adulthood? A meta-analysis
Fröhlich, M., et al. CTA;7:44 DOI 10.1186/s13601-016-0176-5
Prediction and prevention of allergy and asthma in EAACI journals (2016)
Bousquet, J., et al. CTA;7:46 DOI 10.1186/s13601-016-0185-4
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
Bożek A., et al. CTA;7:43 DOI 10.1186/s13601-016-0180-9

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.
Bousquet, J., et al. CTA;7:37 DOI 10.1186/s13601-016-0173-8

- OCTOBER 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN study.
Boelke, G., et al. CTA;7:33 DOI 10.1186/s13601-016-0169-4

Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP—an international interpretation of the MAP (Milk Allergy in Primary Care) guideline
Venter, C., et al. CTA;7:26 DOI 10.1186/s13601-016-0162-y
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
Nurmatov, U., et al. CTA;7:24 DOI 10.1186/s13601-016-0159-6
Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
Asamoah, F., et al. CTA;7:25 DOI 10.1186/s13601-016-0160-0

- AUGUST 2017
National clinical practice guidelines for food allergy and anaphylaxis: an international assessment
Sheikh A., et al. CTA;7:23 DOI 10.1186/s13601-016-0161-z
Diagnosing allergic sensitizations in the third millennium: why clinicians should know allergen molecule structures
Alessandri C., et al. CTA;7:21 DOI 10.1186/s13601-016-0158-7

- MARCH 2017
Three cases of anaphylaxis following injection of a depot corticosteroid with evidence of IgE sensitization to macrogols rather than the active steroid
Brandt, N., et al. CTA;7:2 DOI 10.1186/s13601-016-0138-3
Is fruit and vegetable intake associated with asthma or chronic rhino-sinusitis in European adults? Results from the Global Allergy and Asthma Network of Excellence (GA2LEN) Survey
Garcia-Larsen, V., CTA;7:3 DOI 10.1186/s13601-016-0140-9

Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria
van den Elzen, MT., et al. CTA;7:4 DOI 10.1186/s13601-016-0141-3

- JANUARY 2017
Looking forward to new targeted treatments for chronic spontaneous urticaria
Kocatürk, E., et al. CTA;7:1 DOI 10.1186/s13601-016-0139-2
Is fruit and vegetable intake associated with asthma or chronic rhino-sinusitis in European adults? Results from the Global Allergy and Asthma Network of Excellence (GA2LEN) Survey
Garcia-Larsen, V., et al. CTA;7:3 DOI 10.1186/s13601-016-0140-9

Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals
Lötzsch, B., et al. CTA;6:45 DOI 10.1186/s13601-016-0134-7
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
Bousquet, J., et al. CTA;6:47 DOI 10.1186/s13601-016-0137-4

Hypothesis: may e-cigarette smoking boost the allergic epidemic?
Bousquet, J., et al. CTA;6:40 DOI 10.1186/s13601-016-0130-y
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies
Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al...
Calderon, MA., et al. CTA;6:41 DOI 10.1186/s13601-016-0131-x

A qualitative study of the allergy testing experiences, views and preferences of adult patients
Brown, CE., et al. CTA;6:34 DOI 10.1186/s13601-016-0125-8

- AUGUST 2016
Body mass index and physical activity in early childhood are associated with atopic sensitization, atopic dermatitis and asthma in later childhood 

Byberg, KK., et al., CTA;6:33 DOI 10.1186/s13601-016-0124-9
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies 

Gimenéz-Arnau, AM., et al. CTA;6:32 DOI 10.1186/s13601-016-0120-0
Different risk factor patterns for adult asthma, rhinitis and eczema: results from West Sweden Asthma Study
Rönmark, EP., et al. CTA;6:28 DOI 10.1186/s13601-016-0112-0

- JULY 2016
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Bousquet, J., et al. CTA;6:29 DOI 10.1186/s13601-016-0116-9
Atopic dermatitis prevention in children following maternal probiotic supplementation does not appear to be mediated by breast milk TSLP or TGF-β
Simpson, MR., et al. CTA;6:27 DOI 10.1186/s13601-016-0119-6
Optimizing diagnostic tests for persulphate-induced respiratory diseases
Foss-Skiftesvik, MH., et al. CTA;6:26 DOI 10.1186/s13601-016-0118-7
The impact of the elimination diet on growth and nutrient intake in children with food protein induced gastrointestinal allergies
Meyer, R., et al. CTA;6:25 DOI 10.1186/s13601-016-0115-x

- JUNE 2016
Influence of profilin on sensitisation profiles determined by cutaneous tests and IgE to major allergens in polysensitised patients
Segura, N., et al. CTA;6:23 DOI 10.1186/s13601-016-0114-y
Very low prevalence of IgE mediated wheat allergy and high levels of cross-sensitisation between grass and wheat in a UK birth cohort
Venter, C., et al. CTA;6:22 DOI 10.1186/s13601-016-0111-1
Current challenges facing the assessment of the allergenic capacity of food allergens in animal models
Bøgh, KL., et al. CTA;6:21 DOI 10.1186/s13601-016-0110-2
Nutritional adequacy of a cows’ milk exclusion diet in infancy
Maslin, K., et al. CTA;6:20 DOI 10.1186/s13601-016-0109-8

- MAY 2016
Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study
Schmid JM., et al. CTA;6:19 DOI 10.1186/s13601-016-0107-x
Milk: a postnatal imprinting system stabilizing FoxP3 expression and regulatory T cell differentiation
Melnik, BC., et al. CTA;6:18 DOI 10.1186/s13601-016-0108-9
Cow’s milk allergy in Dutch children: an epigenetic pilot survey
Petrus, NC., et al. CTA;6:2 DOI 10.1186/s13601-016-0105-z

- APRIL 2016
Dietary intake and risk of asthma in children and adults: protocol for a systematic review and meta-analysis
Garcia-Larsen V., et al. CTA;6:17 DOI 10.1186/s13601-016-0106-y
Triclosan promotes epicutaneous sensitization to peanut in mice
Tobar S., et al. CTA;6:13 DOI 10.1186/s13601-016-0102-2
Common environmental chemicals do not explain atopy contrast in the Finnish and Russian Karelia
Koskinen,JP., et al. CTA;6:14 DOI 10.1186/s13601-016-0103-1
The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation test
Santos AF., et al. CTA;6:11 DOI 10.1186/s13601-016-0100-4

- MARCH 2016
Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review 
Dhami S., et al. CTA;6:12 DOI 10.1186/s13601-016-0099-6
Basophil activation test: food challenge in a test tube or specialist research tool? 
Santos A. and Lack G. CTA;6:10 DOI 10.1186/s13601-016-0098-7
Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study 
Reiber R., et al. CTA;6:9 DOI 10.1186/s13601-016-0097-8
Genetic susceptibility for cow’s milk allergy in Dutch children: the start of the allergic march? 
Henneman P., et al. CTA;6:7 DOI 10.1186/s13601-016-0096-9

Measurement and interpretation of skin prick test results 
van der Valk JPM., et al. CTA;6:8 DOI 10.1186/s13601-016-0092-0
Allergen immunotherapy for insect venom allergy: protocol for a systematic review 
Dhami S., et al. CTA;6:6 DOI 10.1186/s13601-016-0095-x
Allergen immunotherapy for allergic asthma: protocol for a systematic review
Dhami S., et al. CTA;6:5 DOI 10.1186/s13601-016-0094-y
An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial 
Chaker AM., et al. CTA;6:4 DOI 10.1186/s13601-016-0093-z

- JANUARY 2016
Incidence and risk factors for food hypersensitivity in UK infants: results from a birth cohort study
Grimshaw K., et al. CTA;6:1 DOI 10.1186/s13601-016-0089-8
What proportion of adult allergy referrals to secondary care could be dealt with in primary care by a GP with special interest?
Smith HE., et al. CTA;6:3 DOI 10.1186/s13601-016-0091-1
Food allergy in mice is modulated through the thymic stromal lymphopoietin pathway
Frossard C., et al. CTA;6:2 DOI 10.1186/s13601-016-0090-2

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose
Demoly P., et al. CTA;5:44 DOI 10.1186/s13601-015-0088-1
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes
Steveling EH., et al. CTA;5:43 DOI 10.1186/s13601-015-0087-2
Expression profiling and functional analysis of Toll-like receptors in primary healthy human nasal epithelial cells shows no correlation and a refractory LPS response
van Tongeren J., et al. CTA;5:42 DOI 10.1186/s13601-015-0086-3
Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
Nembrini C., et al. CTA;5:41 DOI 10.1186/s13601-015-0085-4
Treating chronic spontaneous urticaria using a brief ‘whole person’ treatment approach: a proof-of-concept study
Lindsay K., et al. CTA;5:40 DOI 10.1186/s13601-015-0082-7

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
Price D., et al. CTA;5:39 DOI 10.1186/s13601-015-0083-6
Interchangeability and comparative effectiveness between generic and brand montelukast immediate release tablets after a single oral administration in healthy volunteers
Zaid A., et al. CTA;5:37 DOI 10.1186/s13601-015-0081-8
Treatment of acute rhinitis with a nasal spray containing tramazoline and essential oils: a multicenter, uncontrolled, observational trial
Katona G., et al. CTA;5:38 DOI 10.1186/s13601-015-0084-5

- OCTOBER 2015
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
Hellings P., et al. CTA;5:36 DOI 10.1186/s13601-015-0080-9
Human in vitro induced T regulatory cells and memory T cells share common demethylation of specific FOXP3 promoter region
Bégin P., et al. CTA;5:35 DOI 10.1186/s13601-015-0079-2
Sensitivity to food additives, vaso-active amines and salicylates: a review of the evidence
Skypala I., et al. CTA;5:34 DOI 10.1186/s13601-015-0078-3

The role of IL-33 and mast cells in allergy and inflammation
Saluja R., et al. CTA;5:33 DOI 10.1186/s13601-015-0076-5
Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back

Schrijvers R., et al. CTA;5:31 DOI 10.1186/s13601-015-0073-8

- JULY and AUGUST 2015
Exploratory study of tolerability and immunological effect of a short up-dosing immunotherapy phase with a standardised allergen extract derived from pollen of Olea europaea
Moreno C., et al. CTA;5:27 DOI 10.1186/s13601-015-0070-y
Further studies on the biological activity of hazelnut allergens
Blanc F., et al. CTA;5:26 DOI 10.1186/s13601-015-0066-7
Self-reported adverse reactions and IgE sensitization to common foods in adults with asthma
Rentzos G., et al. CTA;5:25 DOI 10.1186/s13601-015-0067-6
Cough hypersensitivity as a neuro-immune interaction
Song WJ. and Chang YS. CTA;5:24 DOI 10.1186/s13601-015-0069-4
Innate lymphocyte cells in asthma phenotypes
Ozyigit LP., et al. CTA;5:23 DOI 10.1186/s13601-015-0068-5

- MAY and JUNE 2015
Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs
Tanno LK., et al. CTA;5:20 DOI 10.1186/s13601-015-0063-x
Assessment of sensitization to grape and wine allergens as possible causes of adverse reactions to wine: a pilot study
Jaeckels N., et al. CTA;5:21 DOI 10.1186/s13601-015-0065-8
Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults

Rentzos G., et al. CTA;5:22 DOI 10.1186/s13601-015-0064-9

- MARCH and APRIL 2015
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Makatsori M., et al. CTA;5:17 DOI 10.1186/s13601-015-0060-0
Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities
Jensen-Jarolim E., et al. CTA;5:15 DOI 10.1186/s13601-015-0059-6
Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
Cherkaoui S., et al. CTA;5:16 DOI 10.1186/s13601-015-0055-x
Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model
Álvarez-Santos M., et al. CTA;5:14 DOI 10.1186/s13601-015-0058-7
Heterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergy
Smit JJ., et al. CTA;5:13 DOI 10.1186/s13601-015-0056-9
A practical approach to vitamin and mineral supplementation in food allergic children
Meyer R., et al. CTA;5:11 DOI 10.1186/s13601-015-0054-y
Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification of a Danish patient cohort according to EAACI/ENDA guidelines
Nissen CV., et al. CTA;5:10 DOI 10.1186/s13601-015-0052-0

- JANUARY 2015
Influence of the route of exposure and the matrix on the sensitization potency of a major cows' milk allergen

Wavrin S., et al. CTA;5:3 DOI 10.1186/s13601-015-0047-x
The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice
Santos AF., et al. CTA;5:2 DOI 10.1186/s13601-014-0044-5
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
Verheggen BG., et al. CTA;5:1 DOI 10.1186/s13601-025-0045-z
Last updated 21 June 2019
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback